Metabolic Alterations in Renal and Prostate Cancer

被引:21
作者
Ciccarese, Chiara [1 ]
Santoni, Matteo [2 ]
Massari, Francesco [1 ]
Modena, Alessandra [1 ]
Piva, Francesco
Conti, Alessandro
Mazzucchelli, Roberta
Cheng, Liang
Lopez-Beltran, Antonio
Scarpelli, Marina
Tortora, Giampaolo [1 ]
Montironi, Rodolfo
机构
[1] Univ Verona, Azienda Osped Univ Integrata, Med Oncol, I-37100 Verona, Italy
[2] Polytech Univ Marche, AOU Osped Riuniti, Clin Oncol Med, Ancona, Italy
关键词
Cancer metabolism; glycolysis; lipogenesis; prostate cancer; renal cell carcinoma; warburg effect; FATTY-ACID SYNTHASE; HYPOXIA-INDUCIBLE FACTORS; TUMOR-SUPPRESSOR PROTEIN; LIPID RAFTS; CELL CARCINOMA; KIDNEY CANCER; EXPRESSION; TARGETS; GROWTH; GENE;
D O I
10.2174/1389200216666151015112356
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis. Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches. Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 61 条
[21]   Upstream and downstream of mTOR [J].
Hay, N ;
Sonenberg, N .
GENES & DEVELOPMENT, 2004, 18 (16) :1926-1945
[22]   ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis [J].
Ishikawa, Kaori ;
Takenaga, Keizo ;
Akimoto, Miho ;
Koshikawa, Nobuko ;
Yamaguchi, Aya ;
Imanishi, Hirotake ;
Nakada, Kazuto ;
Honma, Yoshio ;
Hayashi, Jun-Ichi .
SCIENCE, 2008, 320 (5876) :661-664
[23]   HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing [J].
Ivan, M ;
Kondo, K ;
Yang, HF ;
Kim, W ;
Valiando, J ;
Ohh, M ;
Salic, A ;
Asara, JM ;
Lane, WS ;
Kaelin, WG .
SCIENCE, 2001, 292 (5516) :464-468
[24]   Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver [J].
Jiang, Weiqin ;
Zhu, Zongjian ;
Thompson, Henry J. .
CANCER RESEARCH, 2008, 68 (13) :5492-5499
[25]   BINDING OF THE VONHIPPEL-LINDAU TUMOR-SUPPRESSOR PROTEIN TO ELONGIN-B AND ELONGIN-C [J].
KIBEL, A ;
ILIOPOULOS, O ;
DECAPRIO, JA ;
KAELIN, WG .
SCIENCE, 1995, 269 (5229) :1444-1446
[26]   Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein [J].
Kondo, K ;
Klco, J ;
Nakamura, E ;
Lechpammer, M ;
Kaelin, WG .
CANCER CELL, 2002, 1 (03) :237-246
[27]   Lipid rafts, cholesterol, and the brain [J].
Korade, Zeljka ;
Kenworthy, Anne K. .
NEUROPHARMACOLOGY, 2008, 55 (08) :1265-1273
[28]   Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer [J].
Langbein, Sigrun ;
Frederiks, Wilma M. ;
zur Hansen, Axel ;
Popa, Juljane ;
Lehmann, Jan ;
Weiss, Christel ;
Alken, Peter ;
Coy, Johannes F. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (11) :2422-2428
[29]   mTOR Signaling in Growth Control and Disease [J].
Laplante, Mathieu ;
Sabatini, David M. .
CELL, 2012, 149 (02) :274-293
[30]  
Lee Minjong, 2015, World J Biol Chem, V6, P148, DOI 10.4331/wjbc.v6.i3.148